News + Filings Transactions
|
LAV Biosciences Fund V, L.P.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/23/2022 | Terns Pharmaceuticals, Inc. | | Sale | Common Stock | 1000k | $5.50 | $5.5M | See footnotes | 11/23/2022 |
| 11/23/2022 | Terns Pharmaceuticals, Inc. | | Sale | Common Stock | 333.3k | $5.50 | $1.8M | See footnotes | 11/23/2022 |
| 11/23/2022 | Terns Pharmaceuticals, Inc. | | Sale | Common Stock | 166.7k | $5.50 | $916.7k | See footnotes | 11/23/2022 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Common Stock | 1.4M | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Common Stock | 696.4k | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Common Stock | 1.3M | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Common Stock | 1.4M | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series A Preferred Stock | 1.4M | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series A Preferred Stock | 696.4k | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series B Preferred Stock | 952.4k | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series C Preferred Stock | 334.3k | $0.00 | $0 | See footnotes | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series C Preferred Stock | 1.4M | $0.00 | $0 | See footnotes | 02/09/2021 |
|